Re: USA ZHCLF investors

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

RVXoldtimer

Rank: President [?]

Points: 3190 [?]

Votes: 23 Score: 3.7 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: USA ZHCLF investors

in response to

Re: USA ZHCLF investors

KOO-KOO2

posted on Oct 30, 2022 04:07PM

Koo - I can't argue with that but that is what it is. When the RPSs were awarded to Zenith as a corp. rather than individual Zenith shareholders, that is the result.

2 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply